source
- CAR-T biotech Kelonia rebounds from cash crises to a $3 billion sale, while drugmakers explore Prescribery partnershipThe latest episode of STAT's "The Readout LOUD" podcast focuses on a dramatic turnaround at a CAR‑T biotech that faced near‑bankruptcy three times before being bought for more than $3 billion. The…
- Opinion: Dropping the flu vaccine requirement puts U.S. military readiness at riskSince the 1918 pandemic, the military has acknowledged the threat of influenza. Now that’s changing.